Home › Funds › LEUTHOLD GROUP, LLC › ELV

LEUTHOLD GROUP, LLC position in ELV

ELEVANCE HEALTH INC FORMERLY · Health Care

LEUTHOLD GROUP, LLC reported holding 20,732 shares of ELV (ELEVANCE HEALTH INC FORMERLY) in its Q3 2026 13F filing — a position valued at US$8.1M, representing 0.76% of its reported portfolio and ranking #47 among its reported holdings. LEUTHOLD GROUP, LLC has disclosed ELV holdings in 8 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)20.73K sh
Reported value held$8.06M
Portfolio Weight0.76%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How LEUTHOLD GROUP, LLC's ELV position evolved

LEUTHOLD GROUP, LLC first disclosed a stake in ELV in Q3 2023 at 14,974 shares (US$6.5M). The position peaked in Q3 2026 at 20,732 shares, worth US$8.1M. Across 8 filings, LEUTHOLD GROUP, LLC increased the stake 2 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 20,732 shares valued at US$8.1M — an increase of 3,428 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 14.97K $6.52M New
Q4 2023 15.21K $7.17M Add
Q1 2024 15.12K $7.84M Reduce
Q2 2024 13.55K $7.34M Reduce
Q3 2024 12.70K $6.60M Reduce
Q4 2025 22.53K $7.90M New
Q2 2026 17.30K $6.69M New
Q3 2026 20.73K $8.06M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ELV and 13F data

ELV (ELEVANCE HEALTH INC FORMERLY) is a Health Care company. 23 other funds we track also report a position in ELV — the largest reported positions include Wellington Management Group (US$3.56B), WELLINGTON MANAGEMENT GROUP LLP (US$3.56B), Sanders Capital, LLC (US$2.27B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ELV

All ELV fund holders →

FAQ

How long has LEUTHOLD GROUP, LLC held ELV?

LEUTHOLD GROUP, LLC has disclosed ELV holdings in 8 of the last 13 reported quarters, going back to Q3 2023.

What is LEUTHOLD GROUP, LLC's current position in ELV?

As of Q3 2026, LEUTHOLD GROUP, LLC holds 20.73K shares of ELV (ELEVANCE HEALTH INC FORMERLY), valued at $8.06M, representing 0.76% of its reported portfolio and ranking #47.

Has LEUTHOLD GROUP, LLC been buying or selling ELV?

In the latest 13F filing (Q3 2026), LEUTHOLD GROUP, LLC increased its position in ELV. The position peaked in Q3 2026 at 20.73K shares.

Which other funds hold ELV?

Other major institutional holders of ELV include Wellington Management Group, WELLINGTON MANAGEMENT GROUP LLP, Sanders Capital, LLC, among 23 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.